OABI

NASD OmniAb, Inc.
Sep 30, 2026 · 3:43 AM ET EOD Market Closed

$4.74 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.74, $0.21 below the day’s high of $4.95

YTD change
+156.22%
vs 20-day SMA
+5.64%
vs 200-day SMA
+100.76%

Price ranges

Previous day
$4.62 $4.95
open $4.74 close $4.74
+$0.00 (+0.00%)
Today
$4.62 $4.95
$4.74
Past week
$4.55 $5.00
from $4.58 now $4.74
+$0.16 (+3.49%)
Past month
$3.89 $5.43
from $4.47 now $4.74
+$0.27 (+6.04%)
This year
$1.35 $5.43
from $1.85 now $4.74
+$2.89 (+156.22%)

Price & Performance

+3.18 (+203.85%) / 6M

$1.07$2.49$3.91$5.33Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 29.4% away from all-time highs of $6.72
  • OABI is up 156% since the beginning of the year
  • OABI is up 194% over the past 12 months
  • OABI is up 6% over the past 1 month
  • 7% of all OABI investors are betting against OABI

OABI reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +196.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.05
Earnings momentum +60.7% Quarterly EPS growth
Quarterly change +60.7%

Valuation

P/E ratio N/A
Enterprise value $577.4M
Beta 2.08

Balance sheet & scale

IncomeN/A
Revenue$38.5M
Cash$52.0M
Debt$18.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $689.1M

OmniAb, Inc. operates as a drug discovery company. The firm focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $750.51 -0.23%
IQV IQVIA Holdings Inc $268.99 -0.73%
CRL Charles River Laboratories International, Inc. $295.96 +0.47%
ICLR ICON Plc $170.35 -2.97%
MDGL Madrigal Pharmaceuticals, Inc. $509.44 -1.47%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.